Yuki Kondo

1.2k total citations
65 papers, 833 citations indexed

About

Yuki Kondo is a scholar working on Physiology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Yuki Kondo has authored 65 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 13 papers in Pharmacology and 11 papers in Organic Chemistry. Recurrent topics in Yuki Kondo's work include Lysosomal Storage Disorders Research (16 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Pharmacy and Medical Practices (7 papers). Yuki Kondo is often cited by papers focused on Lysosomal Storage Disorders Research (16 papers), Carbohydrate Chemistry and Synthesis (11 papers) and Pharmacy and Medical Practices (7 papers). Yuki Kondo collaborates with scholars based in Japan, United States and Spain. Yuki Kondo's co-authors include Tetsumi Irie, Yoichi Ishitsuka, Hidetoshi Arima, Toru Takeo, Naomi Nakagata, Keiichi Motoyama, Taishi Higashi, Daisuke Kadowaki, Ken–ichi Yamamura and Takayuki Hoshii and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Yuki Kondo

58 papers receiving 821 citations

Peers

Yuki Kondo
Yuki Kondo
Citations per year, relative to Yuki Kondo Yuki Kondo (= 1×) peers Ferdinand Molnár

Countries citing papers authored by Yuki Kondo

Since Specialization
Citations

This map shows the geographic impact of Yuki Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Kondo more than expected).

Fields of papers citing papers by Yuki Kondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Kondo. The network helps show where Yuki Kondo may publish in the future.

Co-authorship network of co-authors of Yuki Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Kondo. A scholar is included among the top collaborators of Yuki Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Kondo. Yuki Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuchiya, Masami, Daisuke Kikuchi, Yuri Sato, et al.. (2025). Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements. Pharmacoepidemiology and Drug Safety. 34(11). e70264–e70264.
2.
Yamashita, Koji, et al.. (2024). Magnetic assembly of microwires on a flexible substrate for minimally invasive electrophysiological recording. Biosensors and Bioelectronics. 271. 116927–116927.
3.
Ogura, Toru, et al.. (2024). Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis. Journal of Pharmaceutical Health Care and Sciences. 10(1). 60–60.
4.
Kondo, Yuki, Akira Yoshida, Hiroyuki Nishimura, et al.. (2024). Evaluation of a creatinine clearance correction equation based on body fat mass in older Japanese patients with diabetes. Frontiers in Medicine. 11. 1228383–1228383. 1 indexed citations
5.
Kondo, Yuki, et al.. (2024). Factors promoting research activities among Japanese pharmacists: a questionnaire survey. Scientific Reports. 14(1). 2890–2890. 2 indexed citations
6.
Matsumura, Takeshi, Yuki Kondo, Masahiro Manabe, et al.. (2023). Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes. Biomolecules. 13(3). 468–468. 1 indexed citations
7.
Kondo, Yuki, et al.. (2022). Current Status and Issues Regarding Pharmaceutical Management of Patients with Impaired Renal Function in Community Pharmacies:. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48(2). 59–69. 1 indexed citations
8.
Ishitsuka, Yoichi, Yuki Kondo, Toru Takeo, et al.. (2021). Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann–Pick Disease Type C Model Mice. International Journal of Molecular Sciences. 22(1). 452–452. 21 indexed citations
9.
Kondo, Yuki, Yoichi Ishitsuka, Mitsuru Irikura, et al.. (2021). Correction to: Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey. BMC Health Services Research. 21(1). 1 indexed citations
10.
Narita, Yuki, Köichi Fukumoto, Masaki Fukunaga, et al.. (2020). Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model. International Journal of Molecular Sciences. 21(7). 2491–2491. 10 indexed citations
11.
Sugiuchi, Hiroyuki, Yuki Kondo, Yoichi Ishitsuka, et al.. (2020). A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum. Analytical Biochemistry. 613. 114019–114019. 4 indexed citations
12.
Maeda, Yuki, Keiichi Motoyama, Taishi Higashi, et al.. (2019). In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease. Nanomaterials. 9(5). 802–802. 13 indexed citations
13.
Uchida, Mayako, Yuki Kondo, Shinya Suzuki, & Keiko Hosohata. (2019). Evaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database. Annals of Pharmacotherapy. 53(12). 1200–1206. 19 indexed citations
14.
Ishitsuka, Yoichi, Akira Ishii, Yuki Kondo, et al.. (2019). In Vitro and In Vivo Evaluation of 6-O-α-Maltosyl-β-Cyclodextrin as a Potential Therapeutic Agent Against Niemann-Pick Disease Type C. International Journal of Molecular Sciences. 20(5). 1152–1152. 14 indexed citations
15.
Narita, Yuki, Yutaka Kakizoe, Yuki Kondo, et al.. (2019). Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity. International Journal of Molecular Sciences. 20(17). 4140–4140. 11 indexed citations
16.
Naiki, Taku, Yuki Kondo, Tomoya Kataoka, et al.. (2019). Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis. International Journal of Clinical Oncology. 25(4). 541–551. 1 indexed citations
17.
Hashimoto, Naomi, et al.. (2015). Factors affecting serum albumin in the perioperative period of colorectal surgery: a retrospective study. BMC Research Notes. 8(1). 638–638. 15 indexed citations
18.
Kondo, Yuki, Yoichi Ishitsuka, Mitsuru Irikura, et al.. (2014). Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey. BMC Health Services Research. 14(1). 615–615. 14 indexed citations
19.
Sugiuchi, Hiroyuki, Masahiro Manabe, Katsuyoshi Ikeda, et al.. (2014). Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol. Clinica Chimica Acta. 439. 29–37. 13 indexed citations
20.
Ogawa, Yuki, Mitsuru Irikura, Yoichi Ishitsuka, et al.. (2014). Population pharmacokinetics of doxapram in low-birth-weight Japanese infants with apnea. European Journal of Pediatrics. 174(4). 509–518. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026